Editorial Board — Medscape Psychiatry & Mental Health

Board Members

  • Christoph U. Correll, MD
    • Hofstra North Shore Long Island School of Medicine
      Hempstead, New York
      The Zucker Hillside Hospital
      Glen Oaks, New York
  • Bradley Gaynes, MD, MPH
    • University of North Carolina School of Medicine
      Chapel Hill, North Carolina
  • Joseph F. Goldberg, MD
    • Icahn School of Medicine at Mount Sinai
      New York, New York
  • Eric Hollander, MD
    • Albert Einstein College of Medicine
      Spectrum Neuroscience and Treatment Institute
      New York, NY
 

Board Member Details

Christoph U. Correll, MD
Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine, Department of Psychiatry; Hofstra North Shore Long Island School of Medicine, Hempstead, New York; Medical Director, Recognition and Prevention Program, The Zucker Hillside Hospital, Glen Oaks, New York

Christoph U. Correll, MD, has disclosed the following relevant financial relationships:
Serve(d) as consultant and/or advisor to or has received honoraria from: Alkermes, Inc; Allergan; Angelini; Gerson Lehrman Group; IntraCellular Therapies; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Johnson & Johnson; LB Pharma; Lundbeck, Inc; Medavante; Medscape; Merck & Co.; Neurocrine; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; ROVI; SERVIER; Sunovion; Takeda Pharmaceuticals North America, Inc.; Teva Neuroscience, Inc.
Serve(d) as a speaker or a member of a speakers bureau for: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Lundbeck, Inc; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; Sunovion; Takeda Pharmaceuticals North America, Inc.
Received a research grant from: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.
Received income in an amount equal to or greater than $250 from: Alkermes, Inc.; Allergan; Angelini; Gerson Lehrman Group; IntraCellular Therapies; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Johnson & Johnson; LB Pharma; Lundbeck, Inc; Medavante; Medscape; Neurocrine; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; ROVI; SERVIER; Sunovion; Takeda Pharmaceuticals North America, Inc.; Teva Neuroscience, Inc.

Bradley Gaynes, MD, MPH
Bradley Gaynes, MD, MPH

Professor, Department of Psychiatry, Associate Chair of Research Training and Education, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Bradley Gaynes, MD, MPH, has disclosed no relevant financial relationships.

Joseph F. Goldberg, MD
Joseph F. Goldberg, MD

Clinical Professor of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Private practice, Norwalk, Connecticut

Joseph F. Goldberg, MD, MS, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Neurocrine; Supernus; Sunovion
Serve(d) as a speaker or a member of a speakers bureau for: Merck & Co., Inc.; Sunovion; Neurocrine; Takeda-Lundbeck
Received royalties from: American Psychiatric Publishing Inc.

Eric Hollander, MD
Eric Hollander, MD

Professor of Psychiatry & Behavioral Sciences, Albert Einstein College of Medicine, Bronx, New York; Director, Spectrum Neuroscience and Treatment Institute, New York, New York

Eric Hollander, MD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or member of a speakers bureau for: Sunovion
Received research grant from: Roche; Curemark; Neurocrine Biosciences, Inc.

Jeffrey A. Lieberman, MD
Jeffrey A. Lieberman, MD

Chairman, Department of Psychiatry, Columbia University; Director, Department of Psychiatry, New York State Psychiatric Institute, New York, New York

Jeffrey A. Lieberman, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant or member of the advisory board for: Intra-Cellular Therapies; Eli Lilly and Company; Pierre Fabre; Pear Therapeutics, Inc. (unpaid); PsychoGenics (unpaid)
Received support administered through institution (funding or medical supplies) from: Denovo Biopharma; Taisho Pharmaceutical Co., Ltd.; Pfizer, Inc.; Sunovion Pharmaceuticals Inc.; Genentech, Inc.
Received support administered through institution for company-sponsored phase 2, 3, and 4 studies from: Alkermes, Inc.; Allergan, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.
Received honoraria from: Clintara
Received patent from: Repligen Corporation (no royalties)

Jon McClellan, MD
Jon McClellan, MD

Professor, Department of Psychiatry, University of Washington, Seattle; Medical Director, Child Study and Treatment Center, Lakewood, Washington

Jon McClellan, MD, has disclosed the following relevant financial relationship:
Received research grant from: National Institutes of Health

Drew Ramsey, MD
Drew Ramsey, MD

Assistant Clinical Professor, Department of Psychiatry, Columbia University, New York, New York

Drew Ramsey, MD, has disclosed the following relevant financial relationships:
Have a 5% or greater equity interest in: Eat to Beat Depression eCourse
Author: Eat Complete; The Happiness Diet; 50 Shades of Kale

Stephen M. Strakowski, MD
Michael E. Thase, MD

Professor and Chair, Dell Medical School, University of Texas, Austin

Stephen M. Strakowski, MD, has disclosed the following relevant financial relationships:
Received research grant from: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd. (to employer)
Received income in an amount equal to or greater than $250 from: Sunovion (chair of Data and Safety Monitoring Board); Springer (journal editor)